Gaming Realms PLC (LON:GMR) has reported reduced full-year losses and higher revenues for 2019 and said that trading for the first quarter of 2020 came in “ahead of expectations”. Posting results for the year ended December 31, 2019, the mobile gambling games firm reported a loss from continuing activities of £4.6mln, down from £5.6mln in 2018, while revenues jumped by 11.5% to £6.9mln.
Sareum Holdings PLC (LON:SAR), the specialist small molecule drug development business, announced that its CEO, Dr Tim Mitchell, will give a presentation at BioTrinity 2020, which will be delivered digitally from April 28 to May 1, 2020. The group said the presentation will provide an update of Sareum’s two proprietary TYK2/JAK1 kinase inhibitor programmes, SDC-1801 and SDC-1802, targeting autoimmune diseases and cancers, respectively. Dr Mitchell will also highlight the emerging potential of this mechanism to modulate the severe inflammatory responses and respiratory symptoms arising from coronavirus and other viral infections, it added. The presentation will be made through the BioTrinity virtual portal and will be available to registered participants during the conference and until at least May 9 at https://biotrinity.com/showcase. And a copy of the presentation will also be made available on the company’s website.
ANGLE PLC (LON:AGL) (OTCQX:ANPCY) believes its ground-breaking liquid biopsy system could have a role to play helping guide trials of the next wave of cancer immunotherapies Its Parsortix system is used to harvest circulating tumour cells. Now ANGLE’s scientists are using what’s called an immunofluorescence imaging assay to check for programmed death-ligand 1 expression. Known as PDL1, this particular protein helps keep immune cells from attacking non-harmful cells in the body. However, it also allows the cancer cells to trick the immune system and avoid being attacked as foreign. If a PDL1 expression from a patient’s cancer cells is high, she or he will likely benefit from immunotherapy.
Asiamet Resources Limited (LON:ARS) said it has received approval from Bandan Koordinasi Pernanaman Modal (BKPM), the investment co-ordinating body in Indonesia, for a further exploration permit on its KSK project located in Central Kalimantan. The company noted that it has received approvals from the Ministry of Energy and Mineral Resources, the Ministry of Environment and Forestry, with the final approval provided by BKPM. It said the exploration permit allows the company to undertake exploration activity on its key target areas within KSK over the next 2 years.
Sure Ventures PLC (LON:SURE) has said that Sure Valley Ventures, in which it holds a 25.9% stake, participated in a €2.2mln (£1.9mln) funding round for a business named Buymie. Buymie has developed a platform which uses artificial intelligence (AI) to allow customers to access large grocery retailers and receive short notice delivery to a chosen destination in less than an hour. The company has signed a multi-year partnership with Lidl Ireland to provide a personalised online grocery service, while consumers are also able to use Buymie to shop from Tesco in the country.
Arix Bioscience PLC (LON:ARIX) said its portfolio firm, Pharmaxis Ltd (ASX:PXS), has reported that PXS-5505, its treatment for myelofibrosis (MF) bone marrow cancer, is “well tolerated with no safety signals” in a Phase 1b clinical study. In its announcement, Pharmaxis said the trial had demonstrated that the drug “effectively inhibits all enzymes in the lysyl oxidase family that are involved in fibrosis” and that the pre-clinical program, regulatory advice and opinions from leading clinicians supported progression into a Phase 2 study.
IronRidge Resources Ltd (LON:IRR) said it has begun a second phase drill programme at the Zaranou gold project in Côte d’Ivoire. The license borders with Ghana and is along strike from significant operating gold mines including the five million ounce Chirano mine and the 5.5mln ounce Bibiani mine. In an update, the company said it will undertake approximately 8,000 metres of air core drilling and 1,000 metres of reverse circulation drilling.
Supermarket Income REIT PLC (LON:SUPR) announced that it has successfully raised £139.8mln from a substantially oversubscribed placing of 135,748,028 new ordinary shares at 103p each. The group said that, after careful consideration of the level and quality of demand in the Issue alongside the possibility of acquiring additional assets, its board had determined to increase the size of the Issue to £139.8mln from the original level of £100mln, and added that notwithstanding the increased size of the Issue, investor demand substantially exceeded the gross proceeds raised and as such a scaling back exercise was undertaken.
88 Energy Ltd (LON:88E), further to Monday’s bid announcement, noted on Tuesday that it had entered into pre-bid acceptance deeds with certain shareholders of XCD Energy, representing 129.4mln shares, or 18.5% of the voting rights. The company had previously noted that these shareholders had entered pre-acceptance agreements.
Metal Tiger PLC (LON:MTR) has welcomed the decision of its associate Cobre to take full control of its Toucan Gold subsidiary, the vehicle that owns the Perrinnvale project in Western Australia. The resources investor has agreed to invest a further A$310,000 (£161,000) into Cobre to help it fund the transaction, which will see the Aussie-listed company pay cash of A$527,000 and issue 6.16mln shares to buy out the 20% minority owners. Metal Tiger’s investment will maintain its stake in Cobre at 19.9%.
European Metals Holdings Ltd (LON:EMH) (ASX:EMH) said it’s Czech subsidiary Geomet has now received €29.1mln following completion of its deal with power company, CEZ The €29.1mln investment deal between European Metals and CEZ has now completed. Accordingly, CEZ now has a 51% equity interest in Geomet, which is the holder of the licences to the Cinovec project, Europe’s largest hard rock lithium project.
Symphony Environmental Technologies PLC (LON:SYM), a global specialist in technologies to enhance the properties of plastic and some non-plastic products by making them biodegradable and/or to provide protection against threats to health and safety, has said that its preliminary results for the year ended December 31, 2019, will now be announced during May 2020. The group said the short delay is due to slower, as well as additional, internal and external administrative processes caused by the coronavirus (COVID-19) pandemic. However, the company said its board continues to expect the results will be broadly in line with previous guidance to the market. And, as previously stated a trading update on April 6, the board remains confident that the group is in a strong financial position and is, with its suite of highly relevant technologies, well placed in the current environment.
ECR Minerals PLC (LON:ECR), the gold exploration and development company focused on Australia, announced that at its annual general meeting (AGM) held at on Monday all resolutions proposed were passed.
Keywords Studios PLC (LON:KWS), the international technical and creative services provider to the global video games industry, has confirmed that, given the coronavirus (COVID-19) restrictions, it is no longer possible to hold its Annual General Meeting (AGM) in the way that the board had planned and therefore regrettably it cannot allow shareholders to attend in person. The AGM will instead be convened on May 27 at the company’s offices, 39 Earlham Street, London, WC2H 9LT, United Kingdom, with the minimum necessary quorum of two shareholders (chairman and CEO) present in order to conduct the business of the meeting. The group’s board said it strongly encourages shareholders to vote by proxy in lieu of attending in person and shareholders are also encouraged to submit any questions they would like to have answered at the AGM by e-mailing it to email@example.com to be received no later than 22 May 2020. A video link of a presentation by the CEO’s presentation will be made available for shareholders to view from 11.00am on the day of the AGM on the company’s website.
Proactive Research has issued a note on Maxcyte Inc. (LON:MXCT) following the biotech firm’s recent full-year 2019 results. Analyst Emma Ulker commented: “There are a number of positive trends including increasing recognition of the company’s cell engineering technology, which is regarded as the gold standard in non-viral cell engineering, as well as strong momentum from financing in the cell and gene therapy sector, which attracted nearly US$10bn of global financing in 2019.”